Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China

Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China

In the era of precision medicine, with the deepening of the research on malignant tumor driving genes, clinical oncology has fully entered the era of targeted therapy. For non-small-cell lung cancer (NSCLC), the development of targeted drugs targeting driver genes, such as epidermal growth factor re...

Full description

Bibliographic Details
Main Authors: Tao Li MD, Wen-Yu Yang BS, Ting-Ting Liu MD, Yao Li MD, Lu Liu MD, Xuan Zheng MD, Lei Zhao MD, Fan Zhang MD, Yi Hu MD
Format: Article
Language:English
Published: SAGE Publishing 2023-01-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338221148802

Internet

https://doi.org/10.1177/15330338221148802

Similar Items